As of Feb 16
| 0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 3.21, with a high estimate of 5.59 and a low estimate of 1.95. The median estimate represents a +208.48% increase from the last price of 1.04.
The current consensus among 3 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.